Characterisation of pharmacological mechanisms and potential therapeutic uses of FK866
The finding that NAD+ plays a role in a variety of signalling pathways, including gene expression, Ca2+ signalling and DNA repair mechanisms, has sparked interest in the proteins involved in these pathways as potential pharmacological targets for drug development. Recently, FK866, a potent inhibitor...
Main Author: | Ferguson, Niketa |
---|---|
Published: |
University of Plymouth
2017
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.706440 |
Similar Items
-
Identification and pharmacological characterisation of gastric somatostatin receptors
by: Wyatt, Mark Andrew
Published: (1998) -
Clinical pharmacology/therapeutics as a research discipline
by: Lawrence, J. R.
Published: (1978) -
Synthetic studies towards FK-506
by: Stocks, Michael John
Published: (1990) -
Pharmacological characterisation of a novel cannabinoid CB1 receptor allosteric modulator
by: Horswill, James G.
Published: (2011) -
Biophysical and pharmacological characterisation of recombinant and native rat P2X7 receptors
by: Lappin, Sarah Crawford
Published: (2009)